Incyte (INCY) Construction in Progress (2019 - 2022)
Incyte (INCY) posted Construction in Progress of $176.2 million for Q4 2022, down 10.74% on a QoQ basis from $197.4 million in Q4 2021, and down 10.74% year-over-year from $197.4 million in Q4 2021.
Incyte (INCY) Construction in Progress (2019 - 2022) Analysis & Trends
Incyte's Construction in Progress history runs 4 years deep, the most recent figure standing at $176.2 million for Q4 2022.
- Quarterly Construction in Progress fell 10.74% year-over-year to $176.2 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $176.2 million (down 10.74% YoY) and the FY2022 annual result came in at $176.2 million, down 10.74% from the prior year.
- Construction in Progress was $176.2 million for Q4 2022 at Incyte, down from $197.4 million in the prior quarter.
- Across five years, Construction in Progress topped out at $197.4 million in Q4 2021 and bottomed at $2.0 million in Q1 2019.
- A 4-year average of $68.6 million and a median of $23.1 million in 2020 frame the typical range for Construction in Progress.
- Annual changes were most pronounced in 2020 — Construction in Progress surged 810.0% — and 2022, when it slipped 10.74%.
- Incyte's Construction in Progress stood at $13.8 million in 2019, then jumped by 476.09% to $79.5 million in 2020, then soared by 148.3% to $197.4 million in 2021, then declined by 10.74% to $176.2 million in 2022.
- Business Quant data shows INCY's Construction in Progress at $176.2 million in Q4 2022, $197.4 million in Q4 2021, and $140.7 million in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 137.45 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 176.20 Mn |
| Dec 31, 2021 | 197.40 Mn |
| Sep 30, 2021 | 140.70 Mn |
| Jun 30, 2021 | 125.60 Mn |
| Mar 31, 2021 | 19.10 Mn |
| Dec 31, 2020 | 79.50 Mn |
| Sep 30, 2020 | 23.80 Mn |
| Jun 30, 2020 | 22.40 Mn |
| Mar 31, 2020 | 18.20 Mn |
| Dec 31, 2019 | 13.80 Mn |
| Jun 30, 2019 | 3.90 Mn |
| Mar 31, 2019 | 2.00 Mn |